Stability of Ketamine and Its Metabolites Norketamine and Dehydronorketamine in Human Biological Samples
Open Access
- 1 September 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 47 (9) , 1713-1715
Abstract
Ketamine is a NMDA receptor antagonist used since 1970 for the induction of anesthesia. It has a rapid onset and short duration of action, so it is a preferred agent for short-term surgical procedures. Ketamine possesses sedative and analgesic properties and maintains hemodynamic stability; it therefore is used in patients during the neuro-reanimation period ( 1). Ketamine produces posthypnotic emergence reactions, such as prolonged hallucination and delirium. The frequency of ketamine abuse is increasing ( 2), and fatal ketamine poisoning cases have been reported ( 3)( 4).Keywords
This publication has 5 references indexed in Scilit:
- Simultaneous analysis of ketamine and bupivacaine in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbentClinical Chemistry, 1998
- Ketamine—Its Pharmacology and Therapeutic UsesAnesthesiology, 1982
- Studies on the biotransformation of ketamine 1—Identification of metabolites producedin vitro from rat liver microsomal preparationsJournal of Mass Spectrometry, 1981
- KETAMINE INFUSIONS: PHARMACOKINETICS AND CLINICAL EFFECTSBritish Journal of Anaesthesia, 1979